We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microbial Identification Microarray Identifies 300 Oral Bacterial Species

By Labmedica staff writers
Posted on 29 Jan 2008
Molecular analyses based on 16S rRNA sequencing allow the simultaneous detection of about 300 of the most prevalent oral bacterial species, in a single hybridization. More...
The high throughput technology used allows the evaluation of species that cannot yet be grown in vitro.

The Forsyth Institute (Boston, MA, USA) microbial identification microarray service (MIM) enables rapid identification of bacterial species in clinical samples. The first offering, human oral microbe identification microarray (HOMIM), will focus on detection of bacterial profiles from the oral cavity. Scientists can use this service to compare bacterial associations in health vs. disease, monitor the effects of therapy on the oral ecology, and perform microbial perturbation studies.

Hundreds of different species of bacteria are able to live in the human mouth, although these are not usually present in the same mouth at the same time. Many of the oral bacteria have not been identified because they are impossible to grow in culture in the laboratory. Using molecular techniques, the Forsyth laboratories developed new tools, which do not depend on traditional culturing approaches, to hunt for oral microorganisms. Because the causative agents of oral diseases are not fully known, it is probable that many of the novel bacterial species identified by these new methods play important roles in disease.

The oral cavity also encompasses many surfaces, including teeth, the tongue, palate, and the oral mucosa, each coated with a plethora of bacteria. Using HOMIM, the Forsyth scientists have shown that different consortia of bacteria preferentially attach to different oral surfaces.

Philip Stashenko, president and CEO of The Forsyth Institute said, "The expertise of the Forsyth team is unparalleled and it can provide the scientific community with a unique opportunity to carry out global analyses of oral microbial ecology. In the future, we plan to introduce other microarrays which focus on bacteria in different body niches including the GI tract, stomach and skin.”


Related Links:
The Forsyth Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Graphical Abstract (Zeyang Shen et al., Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease, Allergy, 2026. DOI: 10.1111/all.70449)

Infant Skin Microbiome Show Links to Later Eczema and Food Allergies

Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: Under the theme “From Tissue to Answer”, the launch of VisiOmics anchors a comprehensive pathology portfolio spanning tissue and molecular pathology (Photo courtesy of MGI Tech Co., Ltd.)

MGI Launches Automated Multiplex Tissue Staining and Imaging System at ECP 2026

MGI Tech Co., Ltd. (Shenzhen, China) introduced VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence staining and imaging system, at the 38th European Congress of Pathology (ECP 2026)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.